Literature DB >> 8627812

Detection of the latent form of Epstein-Barr virus DNA in the peripheral blood of healthy individuals.

L L Decker1, L D Klaman, D A Thorley-Lawson.   

Abstract

Epstein-Barr virus infects resting B cells in vitro and activates them to continuously proliferating lymphoblasts. Activation is essential for the virus to convert its linear genome to the covalently closed circular episomal form in which it persists in proliferating cells. However, in vivo, Epstein-Barr virus persists in resting B cells. We found that in these cells also the virus is present as an episome, suggesting that the cells must, at some time, have been activated and then returned to a resting state. This is the first direct demonstration, for any herpesvirus, of this form of the viral genome in normal persistently infected tissue. Since no linear viral DNA was detected, we estimate that fewer than 1 in 40 cells replicates the virus in the peripheral blood of healthy donors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8627812      PMCID: PMC190195     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  15 in total

1.  Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes.

Authors:  L Qu; D T Rowe
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

2.  Partial purification of the Epstein-Barr virus and some properties of its DNA.

Authors:  H Schulte-Holthausen; H zur Hausen
Journal:  Virology       Date:  1970-03       Impact factor: 3.616

Review 3.  Epstein-Barr virus strategy in normal and neoplastic B cells.

Authors:  G Klein
Journal:  Cell       Date:  1994-06-17       Impact factor: 41.582

4.  Detection of circular and linear herpesvirus DNA molecules in mammalian cells by gel electrophoresis.

Authors:  T Gardella; P Medveczky; T Sairenji; C Mulder
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

5.  Detection of herpes simplex virus-specific DNA sequences in latently infected mice and in humans.

Authors:  S Efstathiou; A C Minson; H J Field; J R Anderson; P Wildy
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

6.  When Epstein-Barr virus persistently infects B-cell lines, it frequently integrates.

Authors:  E A Hurley; S Agger; J A McNeil; J B Lawrence; A Calendar; G Lenoir; D A Thorley-Lawson
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

7.  Spontaneous outgrowth of Epstein-Barr virus-positive B-cell lines from circulating human B cells of different buoyant densities.

Authors:  Q Y Yao; H Czarnecka; A B Rickinson
Journal:  Int J Cancer       Date:  1991-05-10       Impact factor: 7.396

8.  A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1.

Authors:  F Chen; J Z Zou; L di Renzo; G Winberg; L F Hu; E Klein; G Klein; I Ernberg
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

9.  B cell activation and the establishment of Epstein-Barr virus latency.

Authors:  E A Hurley; D A Thorley-Lawson
Journal:  J Exp Med       Date:  1988-12-01       Impact factor: 14.307

10.  Early events in Epstein-Barr virus infection provide a model for B cell activation.

Authors:  D A Thorley-Lawson; K P Mann
Journal:  J Exp Med       Date:  1985-07-01       Impact factor: 14.307

View more
  53 in total

1.  Quantitative analysis of latent human cytomegalovirus.

Authors:  B Slobedman; E S Mocarski
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

2.  Cells expressing the Epstein-Barr virus growth program are present in and restricted to the naive B-cell subset of healthy tonsils.

Authors:  A M Joseph; G J Babcock; D A Thorley-Lawson
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-Kinase/Akt pathway.

Authors:  R Swart; I K Ruf; J Sample; R Longnecker
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

4.  Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells.

Authors:  Donna Hochberg; Tatyana Souza; Michelle Catalina; John L Sullivan; Katherine Luzuriaga; David A Thorley-Lawson
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

Review 5.  Role of tegument proteins in herpesvirus assembly and egress.

Authors:  Haitao Guo; Sheng Shen; Lili Wang; Hongyu Deng
Journal:  Protein Cell       Date:  2010-12-10       Impact factor: 14.870

Review 6.  EBV Persistence--Introducing the Virus.

Authors:  David A Thorley-Lawson
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

7.  Transcription program of murine gammaherpesvirus 68.

Authors:  DeeAnn Martinez-Guzman; Tammy Rickabaugh; Ting-Ting Wu; Helen Brown; Steven Cole; Moon Jung Song; Leming Tong; Ren Sun
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  Detection of the Epstein-Barr virus in blood and bone marrow mononuclear cells of patients with aggressive B-cell non-Hodgkin's lymphoma is not associated with prognosis.

Authors:  Herlander Marques; Raquel Catarino; Nelson Domingues; Eliane Barros; Catarina Portela; Maria Inês Almeida; Sandra Costa; Rui Manuel Reis; Rui Medeiros; Adhemar Longatto-Filho
Journal:  Oncol Lett       Date:  2012-09-12       Impact factor: 2.967

9.  Points of recombination in Epstein-Barr virus (EBV) strain P3HR-1-derived heterogeneous DNA as indexes to EBV DNA recombinogenic events in vivo.

Authors:  Kazufumi Ikuta; Shamala K Srinivas; Tim Schacker; Jun-ichi Miyagi; Rona S Scott; John W Sixbey
Journal:  J Virol       Date:  2008-09-25       Impact factor: 5.103

10.  A replication-defective gammaherpesvirus efficiently establishes long-term latency in macrophages but not in B cells in vivo.

Authors:  Haiyan Li; Kazufumi Ikuta; John W Sixbey; Scott A Tibbetts
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.